| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| R Steingard, A Khan, A Gonzalez, D B Herzo. Neuroleptic malignant syndrome: review of experience with children and adolescents. Journal of child and adolescent psychopharmacology. vol 2. issue 3. 2012-10-02. PMID:19630630. |
abstract a report of neuroleptic malignant syndrome (nms) in an adolescent patient with bipolar disorder is presented, and findings from a literature review of 35 child and adolescent cases (presenting before age 19) are compared with the reported experience in adults. |
2012-10-02 |
2023-08-12 |
Not clear |
| S R Latz, J T McCracke. Neuroleptic malignant syndrome in children and adolescents: two case reports and a warning. Journal of child and adolescent psychopharmacology. vol 2. issue 2. 2012-10-02. PMID:19630650. |
abstract neuroleptic malignant syndrome (nms) is a potentially fatal disorder associated with the use of neuroleptics. |
2012-10-02 |
2023-08-12 |
Not clear |
| M Azhar, S Varm. Electro-convulsive therapy in neuroleptic malignant syndrome. European psychiatry : the journal of the Association of European Psychiatrists. vol 10. issue 2. 2012-10-02. PMID:19698324. |
a middle aged lady having manic-depressive psychosis developed neuroleptic malignant syndrome (nms) on haloperidol. |
2012-10-02 |
2023-08-12 |
Not clear |
| Naseem A Quresh. Neuroleptic malignant syndrome. Diagnostic and therapeutic dilemmas in a general hospital setting. Neurosciences (Riyadh, Saudi Arabia). vol 13. issue 4. 2012-10-02. PMID:21063378. |
neuroleptic malignant syndrome (nms) is a rare life-threatening condition, usually induced by typical and atypical antipsychotics. |
2012-10-02 |
2023-08-12 |
Not clear |
| R A O'Brien, G B Youn. Neuroleptic malignant syndrome: a review. Canadian family physician Medecin de famille canadien. vol 35. 2012-10-02. PMID:21248945. |
there has recently been interest in neuroleptic malignant syndrome (nms) as the disorder has been better characterized. |
2012-10-02 |
2023-08-12 |
Not clear |
| L W Reinish, R A Remic. Neuroleptic malignant syndrome. Canadian family physician Medecin de famille canadien. vol 34. 2012-10-02. PMID:21253261. |
the neuroleptic malignant syndrome (nms) is a potentially fatal syndrome characterized by diffuse muscular rigidity, pyrexia, sweating, cardiovascular instability, and elevated serum creatinine phosphokinase. |
2012-10-02 |
2023-08-12 |
Not clear |
| K Kosma, B Roumbos, M Mamali, K Xipas, K Kolovou, G Kalogiratos, A Forto. [Neuroleptic Malignant Syndrome after whithdrawal of anticholinergic agents]. Psychiatrike = Psychiatriki. vol 19. issue 3. 2012-10-02. PMID:22218008. |
neuroleptic malignant syndrome (nms) is a rare but a potential lethal condition therefore it always represents a neurological emergency. |
2012-10-02 |
2023-08-12 |
Not clear |
| Nissar Shaikh, Ghanem Al-Sulaiti, Abdel Nasser, Muhammad Ataur Rahma. Neuroleptic malignant syndrome and closed head injury: A case report and review. Asian journal of neurosurgery. vol 6. issue 2. 2012-10-02. PMID:22347333. |
neuroleptic malignant syndrome (nms) is a rare, but potentially lethal neurological emergency. |
2012-10-02 |
2023-08-12 |
Not clear |
| C Andreou, Vp Bozikas, G Koumenis, G Garyfallos, I Giouzepas, K Foka. [Neuroleptic malignant syndrome and atypical antipsychotics: two case reports]. Psychiatrike = Psychiatriki. vol 18. issue 3. 2012-10-02. PMID:22466631. |
neuroleptic malignant syndrome (nms) constitutes the most serious adverse effect of antipsychotic medications. |
2012-10-02 |
2023-08-12 |
Not clear |
| Julian N Trollor, Xiaohua Chen, Kate Chitty, Perminder S Sachde. Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics. The British journal of psychiatry : the journal of mental science. vol 201. issue 1. 2012-10-02. PMID:22626633. |
reports of neuroleptic malignant syndrome (nms) induced by second-generation antipsychotic drugs highlight a propensity for atypical clinical presentations. |
2012-10-02 |
2023-08-12 |
Not clear |
| Paul J Perry, Courtney A Wilbor. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 24. issue 2. 2012-09-06. PMID:22563571. |
serotonin syndrome (ss) and neuroleptic malignant syndrome (nms) are uncommon but potentially life-threatening adverse reactions associated with psychotropic medications. |
2012-09-06 |
2023-08-12 |
Not clear |
| Marzieh Assareh, Laleh Koohi Habib. Afebrile Neuroleptic Malignant Syndrome associated with Fluphenazine decanoate: A case report. Iranian journal of psychiatry. vol 5. issue 2. 2012-09-06. PMID:22952496. |
neuroleptic malignant syndrome (nms) is unusual but could be a lethal reaction associated with neuroleptic drugs. |
2012-09-06 |
2023-08-12 |
Not clear |
| V P Volko. [Pathomorphology of myocardium in the neuroleptic malignant syndrome]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 112. issue 4. 2012-09-04. PMID:22810744. |
it was performed morphometric analysis of 55 cases which formed 4 groups: 1 - control group - 10 patients without neuroleptic treatment and heart diseases; 2 - 12 patients without heart disease treated with antipsychotic drugs; 3 - 17 - without cardiaс pathology who died from neuroleptic malignant syndrome (nms); 4 - 16 patients with neuroleptic cardiomyopathy (ncmp) who died from nms. |
2012-09-04 |
2023-08-12 |
Not clear |
| Jerrin C Mathew, Unnikrishnan Pillai, Alexander Lacass. Extensive Deep Venous Thrombosis in a Patient with Neurolept Malignant Syndrome despite Being on Prophylaxis. Case reports in psychiatry. vol 2011. 2012-08-31. PMID:22937401. |
the risk of venous thromboembolism (vte) in patients with neuroleptic malignant syndrome (nms) and those on antipsychotic medications is well established. |
2012-08-31 |
2023-08-12 |
Not clear |
| Chung-Wei Yang, Ching Lu, Chih-Cheng Wu, Szu-Chi We. Coexistence of neuroleptic malignant syndrome and a hyperosmolar hyperglycemic state. The American journal of emergency medicine. vol 30. issue 5. 2012-08-17. PMID:21514763. |
neuroleptic malignant syndrome (nms) is a rare idiosyncratic disorder characterized by muscle rigidity, hyperthermia, autonomic dysfunction, and altered consciousness. |
2012-08-17 |
2023-08-12 |
Not clear |
| Megan E Musselman, Linda A Browning, Dennis Parker, Suprat Sael. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome. The Annals of pharmacotherapy. vol 45. issue 11. 2012-04-16. PMID:21972252. |
to describe a case of neuroleptic malignant syndrome (nms) associated with the use of prochlorperazine in a patient recently hospitalized for nms secondary to olanzapine. |
2012-04-16 |
2023-08-12 |
Not clear |
| D P Limbu, R B Tajhya, A Limbu, P M Singh, P Batajoo, B Gurung, S Lamichhane, B Ra. Neuroleptic malignant syndrome: case report. Nepal Medical College journal : NMCJ. vol 13. issue 2. 2012-03-27. PMID:22364104. |
neuroleptic malignant syndrome (nms), a potentially fatal complication of neuroleptic therapy is described. |
2012-03-27 |
2023-08-12 |
Not clear |
| Neda Ghaffari, Emily Dossett, Richard H Lee, Paola Aghajania. Antipsychotics leading to neuroleptic malignant syndrome in pregnancy. Obstetrics and gynecology. vol 119. issue 2 Pt 2. 2012-03-25. PMID:22270430. |
neuroleptic malignant syndrome (nms) is characterized by a tetrad of mental status changes, extrapyramidal symptoms, hyperpyrexia, and autonomic instability and can develop after the use of antipsychotics. |
2012-03-25 |
2023-08-12 |
Not clear |
| Steven C Stoner, Amy Berr. Suspected neuroleptic malignant syndrome during quetiapine-clozapine cross-titration. Journal of pharmacy practice. vol 23. issue 1. 2012-03-22. PMID:21507795. |
neuroleptic malignant syndrome (nms) is a physiologic phenomenon that has been associated with the use of both first- and second-generation antipsychotics resultant to their ability to block dopamine blockade in the basal ganglia and hypothalamic regions of the brain. |
2012-03-22 |
2023-08-12 |
Not clear |
| Ming-Che Tu, Cheng-Cheng Hsia. Amisulpride and neuroleptic malignant syndrome. Chang Gung medical journal. vol 34. issue 5. 2012-02-27. PMID:22035899. |
neuroleptic malignant syndrome (nms) is a rare but lethal complication of neuroleptics. |
2012-02-27 |
2023-08-12 |
Not clear |